Search - tctmd.com

Displaying 941 - 960 of 1456

Sort: Relevancy | Date

Presentation LAA 2017

WATCHMAN LAA Closure: Device Description, Implantation Technique, Medications, and Follow-Up

Presenter: Shephal Doshi

July 21, 2017

Presentation LAA 2017

Changing My Transseptal Puncture Location Simplified My LAA Occlusion

Presenter: Dhanunjaya Lakkireddy

July 21, 2017

Presentation LAA 2017

The Spectrum of LAA Closure Devices: Similarities and Differences

Presenter: Horst Sievert

July 21, 2017

Presentation LAA 2017

Case: Complication of TSP

Presenter: Matthew J. Price

July 21, 2017

Presentation LAA 2017

What Have We Learned from Surgical LAA Closure?

Presenter: Subhasis Chatterjee

July 21, 2017

Presentation LAA 2017

Electrical/Ablation Approaches to AFib: Competitive or Complementary With LAA Closure?

Presenter: Vivek Y. Reddy

July 21, 2017

Presentation LAA 2017

Warfarin and NOACs in Non-Valvular Atrial Fibrillation

Presenter: Gregg W. Stone

July 21, 2017

Presentation LAA 2017

Risk Scores and Biomarkers for Stroke and Bleeding: Applications and Recommendations

Presenter: Megan Coylewright

July 21, 2017

Presentation LAA 2017

The Multifaceted Etiology of Stroke: Focus on Atrial Fibrillation and PFO

Presenter: M. Edip Gurol

July 21, 2017

Presentation LAA 2017

ICE for Trans-septal Puncture in an LAA Occlusion Procedure

Presenter: Brij Maini

July 21, 2017

News Conference News SCCT 2017

Seeing Is Believing: Experts Predict an Expanded Role for Cardiac CT in Structural Interventions

Yael L. Maxwell

July 08, 2017

Presentation TVT 2017

Managing AS Patients With Atrial Fibrillation After TAVR Pharmacotherapy Considerations and LAAC Possibilities

Presenter: Samir R. Kapadia

June 16, 2017

Presentation TVT 2017

Combination Transcatheter Mitral Valve Interventions and LAA Occlusion Clinical and Technical Considerations

Presenter: Michael J. Mack, Fabian Nietlispach

June 15, 2017

News Conference News EuroPCR 2017

EWOLUTION Analysis Backs LAA Closure in High-Risk Patients Taking DAPT, Not Warfarin, After Procedure

Michael O'Riordan

May 24, 2017

Presentation EuroPCR 2017

Efficacy and Safety of LAA Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation: 1-year FU of the EWOLUTION trial

Presenter: Lucas Boersma, Martin W. Bergmann

May 18, 2017

Podcast

Episode 13: Left Main Revascularization, Bifurcation Stenting, and LAA Closure

May 17, 2017

News Daily News

‘Reassuring’ Results for Watchman LAA Closure Device Seen in EWOLUTION Registry

Todd Neale

May 17, 2017

News Opinion Fellow Talk

Early Career Tips from a Master Interventionalist

Ankur Kalra

May 12, 2017

Presentation SCAI 2017

Watchman LAAO: Implant Procedure and Patient Management

Presenter: Chadi Alraies

May 11, 2017

Presentation Fellows 2017

LAA Closure: Data, Devices, and Technique

Presenter: Susheel Kodali, Mark Reisman

April 09, 2017

Advertisement

WATCHMAN LAA Closure: Device Description, Implantation Technique, Medications, and Follow-Up

Changing My Transseptal Puncture Location Simplified My LAA Occlusion

The Spectrum of LAA Closure Devices: Similarities and Differences

Case: Complication of TSP

What Have We Learned from Surgical LAA Closure?

Electrical/Ablation Approaches to AFib: Competitive or Complementary With LAA Closure?

Warfarin and NOACs in Non-Valvular Atrial Fibrillation

Risk Scores and Biomarkers for Stroke and Bleeding: Applications and Recommendations

The Multifaceted Etiology of Stroke: Focus on Atrial Fibrillation and PFO

ICE for Trans-septal Puncture in an LAA Occlusion Procedure

Seeing Is Believing: Experts Predict an Expanded Role for Cardiac CT in Structural Interventions

Managing AS Patients With Atrial Fibrillation After TAVR Pharmacotherapy Considerations and LAAC Possibilities

Combination Transcatheter Mitral Valve Interventions and LAA Occlusion Clinical and Technical Considerations

EWOLUTION Analysis Backs LAA Closure in High-Risk Patients Taking DAPT, Not Warfarin, After Procedure

Efficacy and Safety of LAA Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation: 1-year FU of the EWOLUTION trial

Episode 13: Left Main Revascularization, Bifurcation Stenting, and LAA Closure

‘Reassuring’ Results for Watchman LAA Closure Device Seen in EWOLUTION Registry

Early Career Tips from a Master Interventionalist

Watchman LAAO: Implant Procedure and Patient Management

LAA Closure: Data, Devices, and Technique

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content